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Abstract 
Purpose:  This study was carried out to analyze the prevalence of hepatitis C Virus in patient going through eye 
surgery. 
Material and Method:  This was a prospective observational study conducted at the Sindh Institute of 
Ophthalmology and Visual Sciences (SIOVS) Hyderabad from July 2013 to June 2015. In this study, evaluation 
of 5600 patients of various ages undergoing eye surgeries and being unaware of hepatitis C infection were 
included. Each patient was serologically screened by immunochromatography (ICT method) for qualitative 
detection of antibodies for Hepatitis C before surgery. 
Result:  Two thousand two hundred sixty four (40.43%) patients were male and 3336 (59.57%) were female. 
Large numbers of patients were in 4th and 5th decade of life in both the sexes. Of these 5600 patients, 713 
(12.73%) were serologically positive for hepatitis C antibodies. Majority of them were female (58.44%). 
Conclusion:  The prevalence of hepatitis C antibodies positive is higher in our population. Therefore, it is 
mandatory to screen every patient for hepatitis C and B before any surgical procedure. The surgeon and health 
care professional should take protective measures. The used infected materials should be destroyed properly. 
 
1. INTRODUCTION: 
Infection with Hepatitis C virus (HCV) is a major cause of Liver disease, cirrhosis and hepatocellular carcinoma. 
Hepatitis C virus is small, with a diameter of about 50 nm, enveloped, single stranded, positive sense RNA virus. 
The average incubation period is 7-8 weeks with a range of 2-26 weeks. It is primarily a blood borne or 
parenterally transmitted infection. Vehicles and routes of parenteral transmission include; contaminated blood 
and blood products, needle sharing, contaminated instruments (eg: in haemodialysis, re-use of contaminated 
medical devices, tattooing devices, acupuncture needles, razors) and occupational and nosocomial 
exposure.(2000; Jain et al. 2003; K. 2003; Mahmood and Iqbal 2008; Mileo et al. 2015) 
Only a relatively small fraction of HCV infections are symptomatic. Most infected individuals remain 
asymptomatic but often it leads to jaundice, anorexia (poor appetite) and diarrhea and presumably it remains 
undiagnosed and leads to chronic carrier state. In these affected individuals; almost 70-85% develop chronic 
infection.(K. 2003; Naeem et al. 2012) It stands to reason that an occupational risk for transmission of HCV in 
the health care setting, where unknown carriers of HCV are undergoing different procedures, in which there is a 
chance of contact of percutaneous blood, including transmission from infected patients to staff, from patient to 
patient, and from infected providers to patients.(Alain et al. ; Mahmood and Iqbal 2008) Presence of anti HCV 
antibodies in blood indicate that the person is infected with Hepatitis C virus and may transmit the virus to 
others.(Mahmood and Iqbal 2008) Anti-HCV in hospitalized surgical patients is very high. There is a lack of 
routine serological screening prior to surgery which is one of the factors responsible for increased disease 
transmission. The major risk factors include; re-use of contaminated syringes, surgical instruments and 
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improperly screened blood products.(Naeem et al. 2012) Without meticulous attention towards infection control 
and disinfection and sterilization procedures, the risk for transmission of blood borne pathogens in the health 
care setting is magnified. 
The study was conducted to find out the incidence of HCV antibodies in patients undergoing surgery at Sindh 
Institute of Ophthalmology and Visual Sciences (SIOVS) Hyderabad. This is one of the largest tertiary care 
centre in Sindh. This institution is a great referral centre for whole interior Sindh province. 
 
2. MATERIAL AND METHODS 
This prospective observational study was carried out at the Sindh Institute of Ophthalmology and Visual 
Sciences (SIOVS) Hyderabad from July 2013 to June 2015. A total of 5600 patients undergoing eye surgery, 
who were unaware of hepatitis C infection were included in this study. The blood samples of all these patients 
were taken in the institute laboratory Scientific Ophthalmic Diagnosis & Research Lab. Each patient was 
serologically screened, by using immunochromatography (ICT method) for qualitative detection of Hepatitis C 
virus antibodies, to find the carrier status of patients before surgery. Results, that were found positive on 
screening test, were confirmed by ELISA (Enzyme-Linked Immunosorbent Assay) method (4th generation 
ELISA).  We entered all the data in SPSS version 16 and we measured the prevalence and percentage of all 
variables. 
 
3. RESULTS 
A total number of 5600 patients were operated during the study, two thousand two hundred sixty four (40.43%) 
patients were male and 3336 (59.57%) were female.  
Of these 5600 patients, 713 (12.73%) were serologically positive for hepatitis C antibodies (Figure 1). Majority 
of them were female (58.44%).(Table 1). Large numbers of patients 578 (81.06%) were in 4th and 5th decade of 
life in both sexes. .(Figure 2) 
 
Figure 1: A: Serologically positive for hepatitis C antibodies 
        B: Serologically negative for hepatitis C antibodies 
            
 
 
 
 
   A                             B 
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Table 1: Incidence of Anti Hepatitis C in different age group 
 
Age Group 
Male Female Overall  
N % N % N % 
21-30 32 7.90 15 4.87 47 6.59 
31-40 50 12.35 35 11.36 85 11.92 
41-50 108 26.67 75 24.35 183 25.67 
>50 215 53.09 180 58.44 395 55.40 
Total 405 100.00 308 100.00 713 100.00 
 
 
 
Figure 1: Incidence of Anti Hepatitis C in different age group 
 
4. DISCUSSION 
In 1989 the virus responsible for most transfusion-associated non-A non-B hepatitis was identified and cloned, 
and named hepatitis C virus (HCV).(2000; Farci 2002)  Shortly after the cloning of HCV, this new isolated virus 
was discovered to be the cause of approximately 90% of non A, non B hepatitis in the United States.(Jatoi, 
Narsani, and Kumar 2009) 
HCV infections are common worldwide. According to World Health Organization (WHO) it is estimated to be 
approximately 3% corresponding to170 million infected persons.(2000) HCV is responsible for 50-76% of all 
liver cancer cases, and two thirds of all liver transplants in the developed world.(Umar et al. 2010) It appears to 
be endemic in most parts of world. Regional variation exists in the prevalence of HCV infection from high 
endemic area to non-endemic area(Muhammad and Jan 2005). The prevalence of hepatitis varies from country to 
country. At times it will also vary among different regions of the same country. The epidemiological estimates 
by WHO show that the prevalence of hepatitis C is low (<1%) in Australia, Canada and northern Europe, and 
about 1% in countries of medium endemism, such as the USA and most of Europe. It is high (>2%) in many 
countries of Africa, Latin America, Central and South-East Asia.(ul Huda et al. 2013) In Pakistan HCV is highly 
endemic and its incidence is increasing since last few years. The incidence of anti HCV Positive in our study is 
12.73 % and our previous study was 29.60%(Jatoi et al. 2009). W Ul Huda et al(ul Huda et al. 2013) reported 
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17.33% incidence of HCV infection among their operated patients whereas study conducted by Khurrum,M et 
al(Khurum 2003) reported 6% incidence of anti HCV antibodies in health care workers in a local hospital.  
Concerning demographic variables, the increase in the risk for HCV seropositive incidences increased with 
increasing age i.e 6.59% at the age of 20 to 30 years whereas 25.67% at the age of 40 to 50 years. In our study, 
the higher prevalence of hepatitis C were in the age range of 30 – 60 years, which is comparable to the study of 
Talpur,AA et., al(Talpur et al. 2006) in which 65% positive patients were above the age of 40 years. 
This study shows that the prevalence of hepatitis C is quite high. Doctors and paramedical staff in surgical 
practice are at high risk of acquiring blood borne diseases from the patients on whom they operate.  
 
5. CONCLUSION 
The aim of the present study was to assess the prevalence of HCV infection among preoperative patients. The 
incidence of hepatitis C antibodies positive is higher in our population. Therefore, it is mandatory to screen every 
patient for hepatitis C and B before any surgical procedure. The surgeon and health care professional should 
protect themselves by using protective mask, eye protection glasses, double gloves before handling infected 
cases. The used infected material, needles and other waste material should be destroyed properly using Biosafety 
protocols. Healthcare professionals should also be screened routinely as they are exposed to patient for long 
periods of time. 
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